Nonalcoholic fatty liver disease(NAFLD)is becoming a frequent liver disease,especially in patients with metabolic syndrome and especially in Western countries.Complications of NAFLD comprise progressive fibrosis,cirrh...Nonalcoholic fatty liver disease(NAFLD)is becoming a frequent liver disease,especially in patients with metabolic syndrome and especially in Western countries.Complications of NAFLD comprise progressive fibrosis,cirrhosis and hepatocellular carcinoma.NAFLD also represents an independent risk factor for cardiovascular disease,extrahepatic neoplasia and other organ damage,such as renal insufficiency.Given the epidemiological importance of the disease,new developments in specific treatment of the disease and the wide availability of noninvasive techniques in estimating steatosis and fibrosis,NAFLD should be subject to screening programs,at least in countries with a high prevalence of the disease.The review discusses prerequisites for screening,cost-effectiveness,current guideline recommendations,suitability of techniques for screening and propositions for the following questions:Who should be screened?Who should perform screening?How should screening be performed?It is time for a screening program in patients at risk for NAFLD.展开更多
文摘Nonalcoholic fatty liver disease(NAFLD)is becoming a frequent liver disease,especially in patients with metabolic syndrome and especially in Western countries.Complications of NAFLD comprise progressive fibrosis,cirrhosis and hepatocellular carcinoma.NAFLD also represents an independent risk factor for cardiovascular disease,extrahepatic neoplasia and other organ damage,such as renal insufficiency.Given the epidemiological importance of the disease,new developments in specific treatment of the disease and the wide availability of noninvasive techniques in estimating steatosis and fibrosis,NAFLD should be subject to screening programs,at least in countries with a high prevalence of the disease.The review discusses prerequisites for screening,cost-effectiveness,current guideline recommendations,suitability of techniques for screening and propositions for the following questions:Who should be screened?Who should perform screening?How should screening be performed?It is time for a screening program in patients at risk for NAFLD.
